# Amylyx Pharmaceuticals, Inc.: Form 8-K, filed Dec 7, 2023

- Company: [Amylyx Pharmaceuticals, Inc.](/companies/amlx.md) (CIK 1658551)
- Form: 8-K
- Filed: 2023-12-07
- Accepted by EDGAR: Dec 7, 2023, 07:00 ET
- Period: 2023-12-07
- Accession: 0001193125-23-290302
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1658551/000119312523290302/d646901d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1658551/000119312523290302/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1658551/000119312523290302/d646901d8k.htm

Filed Dec 7, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-290302. Last ingested by Listed: Nov 10, 2026, 03:21 ET. No prices; not investment advice.